Market Overview:
The global drug screening market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of drug abuse and the subsequent need for drug screening. Additionally, the growing demand for rapid testing devices is also contributing to the growth of this market. The global drug screening market is segmented on the basis of type, application, and region. On the basis of type, it is divided into immunoassay analyzers, chromatography, breath analyzers, rapid testing devices, assay kits and reagents. Immunoassay analyzers are further classified into ELISA kits and lateral flow assays (LFAs). Chromatography is further classified into gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC/MS/MS). Breath analyzers are further classified into semiconductor oxide sensors (SOS) based breathalyzers and fuel cell breathalyzers. Rapid testing devices are further classified into point-of-care tests (POCTs) and laboratory instruments or centralized instruments .On the basis of application ,the global drug screening marketis segmentedinto hospitals,, research institutes,, biotechnology & pharmaceutical companies,, forensic laboratories,, pain management clinicsand others,.
Product Definition:
Drug Screening is the process of detecting the presence of drugs in a person's system. Drug Screening is important because it can help identify people who are using drugs and may need treatment.
Immunoassay Analyzers:
Immunoassay is a technique that involves the use of antibodies and their ligands for the detection of specific biological molecules. The immunoassay analyzers are used to detect specific substances using an antibody-antigen reaction. Immunoassays have wide applications in biotechnology, pharmaceutical research, clinical diagnosis, food analysis and environmental testing industries. It also has application in drug development &quality control procedures as well as research studies related to human health.
Chromatography:
Chromatography is a technique used for the separation of compounds based on their molecular weight. It is also used to separate and identify molecules according to different properties such as boiling point, density, and polarity. The technology has been around since the early 20th century but only in recent years has it become a vital tool in drug development processes due to its increased sensitivity and ability to provide detailed information about an individual compound.
Application Insights:
Based on application, the global market is segmented into hospitals, research institutes, biotechnology & pharmaceutical companies and others. Hospitals were estimated to be the largest revenue generating centers in 2017. The hospital segment is further divided into primary healthcare facilities and secondary/tertiary healthcare facilities based on location. Factors such as government support for initiatives that improve population health are expected to drive growth over the forecast period.
The research institute segment held a significant share of the overall revenue in 2017 owing to increasing R&D activities pertaining various drugs screening applications at these institutions across the globe. Drug discovery plays an important role in new drug development process which involves several steps from identification of target molecules to lead optimization & finalization phases for clinical trials etcetera (Figure 1). Various organizations involved in drug discovery & testing such as universities or private institutions collaborating with biopharmaceutical companies are likely to boost product demand globally over next few years (Figure 2).
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market over the forecast period. The growth can be attributed to factors such as increasing investment by governments in healthcare infrastructure development and rising prevalence of infectious diseases. For instance, in India, Ministry of Health & Family Welfare (MoHFW) has planned to spend USD X trillion for improving healthcare facilities across the nation from 2014-15 till 2019-20. In addition, according to a study published by NCBI in 2015; every year around 1 million people die due to drug resistant tuberculosis and this number is anticipated to grow rapidly over the coming years.
However, North America held a substantial share owing its large presence of biotechnology companies involved with R&D activities relatedto infectious disease testing devices.
Growth Factors:
- Increasing demand for drug screening from the workplace to detect drug abuse among employees.
- Growing number of road accidents due to driving under the influence of drugs.
- Stringent government regulations for safe and secure workplaces, transportation, and public places.
- Rising awareness about the ill effects of drug abuse among people across all age groups.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Screening Market Research Report
By Type
Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents
By Application
Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others
By Companies
Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Drug Screening Market Report Segments:
The global Drug Screening market is segmented on the basis of:
Types
Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Express Diagnostics
- Laboratory Corporation of America
- MPD
- Quest Diagnostics
- Roche Diagnostics
- Shimadzu
- Siemens Healthcare
- Thermo Fisher Scientific
- Abbott
Highlights of The Drug Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoassay Analyzers
- Chromatography
- Breath Analyzers
- Rapid Testing Devices
- Assay Kits and Reagents
- By Application:
- Hospitals
- Research Institute
- Biotechnology & Pharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug screening is a process used to identify potential drugs or substances in a person's body. It can be done by using various tests, such as blood, urine, and hair analysis.
Some of the major companies in the drug screening market are Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific, Abbott.
The drug screening market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Screening Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Screening Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Screening Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Screening Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Screening Market Size & Forecast, 2020-2028
4.5.1 Drug Screening Market Size and Y-o-Y Growth
4.5.2 Drug Screening Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunoassay Analyzers
5.2.2 Chromatography
5.2.3 Breath Analyzers
5.2.4 Rapid Testing Devices
5.2.5 Assay Kits and Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Research Institute
6.2.3 Biotechnology & Pharmaceutical Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Screening Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Screening Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunoassay Analyzers
9.6.2 Chromatography
9.6.3 Breath Analyzers
9.6.4 Rapid Testing Devices
9.6.5 Assay Kits and Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Research Institute
9.10.3 Biotechnology & Pharmaceutical Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunoassay Analyzers
10.6.2 Chromatography
10.6.3 Breath Analyzers
10.6.4 Rapid Testing Devices
10.6.5 Assay Kits and Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Research Institute
10.10.3 Biotechnology & Pharmaceutical Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunoassay Analyzers
11.6.2 Chromatography
11.6.3 Breath Analyzers
11.6.4 Rapid Testing Devices
11.6.5 Assay Kits and Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Research Institute
11.10.3 Biotechnology & Pharmaceutical Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunoassay Analyzers
12.6.2 Chromatography
12.6.3 Breath Analyzers
12.6.4 Rapid Testing Devices
12.6.5 Assay Kits and Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Research Institute
12.10.3 Biotechnology & Pharmaceutical Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunoassay Analyzers
13.6.2 Chromatography
13.6.3 Breath Analyzers
13.6.4 Rapid Testing Devices
13.6.5 Assay Kits and Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Research Institute
13.10.3 Biotechnology & Pharmaceutical Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Screening Market: Competitive Dashboard
14.2 Global Drug Screening Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Express Diagnostics
14.3.3 Laboratory Corporation of America
14.3.4 MPD
14.3.5 Quest Diagnostics
14.3.6 Roche Diagnostics
14.3.7 Shimadzu
14.3.8 Siemens Healthcare
14.3.9 Thermo Fisher Scientific
14.3.10 Abbott
